Charles River Laboratories International (CRL) Competitors $165.17 -1.81 (-1.08%) As of 11:27 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. A, MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Charles River Laboratories International (NYSE:CRL) and Agilent Technologies (NYSE:A) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, valuation and dividends. Which has more risk & volatility, CRL or A? Charles River Laboratories International has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Which has preferable valuation and earnings, CRL or A? Agilent Technologies has higher revenue and earnings than Charles River Laboratories International. Agilent Technologies is trading at a lower price-to-earnings ratio than Charles River Laboratories International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCharles River Laboratories International$4.05B2.11$474.62M$0.151,115.28Agilent Technologies$6.51B5.34$1.29B$4.3528.04 Does the media prefer CRL or A? In the previous week, Agilent Technologies had 30 more articles in the media than Charles River Laboratories International. MarketBeat recorded 47 mentions for Agilent Technologies and 17 mentions for Charles River Laboratories International. Agilent Technologies' average media sentiment score of 0.96 beat Charles River Laboratories International's score of 0.52 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Charles River Laboratories International 9 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 27 Very Positive mention(s) 4 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts rate CRL or A? Charles River Laboratories International currently has a consensus price target of $189.77, suggesting a potential upside of 13.44%. Agilent Technologies has a consensus price target of $146.15, suggesting a potential upside of 19.84%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Agilent Technologies is more favorable than Charles River Laboratories International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charles River Laboratories International 1 Sell rating(s) 15 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.94Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community prefer CRL or A? Agilent Technologies received 372 more outperform votes than Charles River Laboratories International when rated by MarketBeat users. Likewise, 71.08% of users gave Agilent Technologies an outperform vote while only 59.61% of users gave Charles River Laboratories International an outperform vote. CompanyUnderperformOutperformCharles River Laboratories InternationalOutperform Votes49359.61% Underperform Votes33440.39% Agilent TechnologiesOutperform Votes86571.08% Underperform Votes35228.92% Do insiders & institutionals believe in CRL or A? 98.9% of Charles River Laboratories International shares are owned by institutional investors. 1.3% of Charles River Laboratories International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is CRL or A more profitable? Agilent Technologies has a net margin of 19.27% compared to Charles River Laboratories International's net margin of 0.52%. Agilent Technologies' return on equity of 25.56% beat Charles River Laboratories International's return on equity.Company Net Margins Return on Equity Return on Assets Charles River Laboratories International0.52% 14.69% 6.79% Agilent Technologies 19.27%25.56%13.47% SummaryAgilent Technologies beats Charles River Laboratories International on 14 of the 18 factors compared between the two stocks. Remove Ads Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$8.55B$3.64B$5.74B$19.74BDividend YieldN/A2.02%4.55%3.75%P/E Ratio1,115.28110.1724.7234.14Price / Sales2.11121.74397.1128.93Price / Cash7.4834.5738.1617.54Price / Book2.472.727.134.65Net Income$474.62M$113.28M$3.20B$1.02B7 Day Performance-5.49%-4.63%3.63%1.47%1 Month Performance0.11%-19.81%7.42%-0.75%1 Year Performance-36.99%-9.51%15.37%7.33% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.4572 of 5 stars$165.17-1.1%$189.77+14.9%-38.6%$8.45B$4.05B1,101.3021,800AAgilent Technologies4.0391 of 5 stars$122.63+1.2%$146.15+19.2%-17.3%$34.96B$6.51B28.1917,900Analyst RevisionMTDMettler-Toledo International3.8105 of 5 stars$1,234.56+0.4%$1,380.50+11.8%-8.7%$25.82B$3.87B30.4618,000Positive NewsWATWaters3.5688 of 5 stars$378.65+0.4%$391.07+3.3%+7.4%$22.50B$2.96B35.357,900ILMNIllumina4.6615 of 5 stars$85.68+0.1%$140.90+64.4%-35.9%$13.57B$4.37B-11.169,030Positive NewsTECHBio-Techne4.8968 of 5 stars$62.58+0.7%$82.14+31.3%-14.6%$9.89B$1.20B63.213,100Positive NewsBIOBio-Rad Laboratories4.5125 of 5 stars$256.35+0.7%$395.20+54.2%-26.6%$7.18B$2.57B-3.947,700Positive NewsHigh Trading VolumeBRKRBruker4.7555 of 5 stars$46.94+2.2%$70.50+50.2%-52.6%$7.12B$3.37B61.768,520PACBPacific Biosciences of California2.3957 of 5 stars$1.24+1.6%$2.79+125.1%-63.9%$339.59M$154.01M-0.76730HBIOHarvard Bioscience3.9126 of 5 stars$0.70+7.3%N/A-85.6%$30.32M$97.73M-2.11490Analyst ForecastNegative NewsGap UpTMOThermo Fisher Scientific4.8781 of 5 stars$519.30-0.5%$653.23+25.8%-10.8%$195.91B$42.88B31.42122,000Positive News Remove Ads Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
